Oklo Receives Startup Authorization for Groves Reactor
Nuclear startup Oklo has received 'startup authorization' from the U.S. Department of Energy (DoE) for its Groves Reactor in Texas under the Reactor Pilot Program (RPP). This milestone allows Oklo to load nuclear fuel and conduct testing toward achieving first criticality, marking a significant regulatory step forward. The RPP was established by executive order in 2025 with the goal of accelerating U.S. reactor deployment through an expedited approval process for reactors tested safely by the DoE. The Groves Reactor project moved from groundbreaking to startup authorization in just over ten months, a historically fast timeline for nuclear projects. Oklo's CEO emphasized that this rapid progress could serve as a model for future commercial deployments of its reactor designs. While not intended for power generation, the Groves Reactor is designed to produce isotopes used in medical treatments like cancer therapy and aims to reduce reliance on foreign sources.
Tickers: $OKLO
Topics: nuclear energy regulation startups